Insights, trends and tips in the business of science.
Top Stories
INTELLECTUAL PROPERTY
A licence to print money
Blazing the path from incubation to acquisition by a large company in a remarkably short time, GlycArt Biotechnology, a spin-off from the Swiss Federal Institute of Technology in Zürich, has been acquired by the Roche Group for 235 million Swiss francs.
IMPERIAL
A piece of the action
An experiment in investment - buying shares directly in a university's scientific portfolio - is under way at Imperial College London.
R&D MANAGEMENT
Long live the corporate lab
In an unusual move to help local start-ups, the University of Cambridge has obtained pledges from a group of venture capitalists to provide more than £500,000 in early-stage funding through a new investment club, Cambridge Venture Partners.
R&D TRENDS
Spintronics - the quick guide
This hot field of research promises to change the electronics industry. A quick guide to what it's about, and who's who in it.
RESOURCES & TOOLS
Patently ridiculous
Technology journalist Barry Fox thinks that the patent system is deliberately designed to make it hard to find out anything.
FACT CHECK
European biotech: straggling ahead
For the biotech industry worldwide, the past few years have been stressful. The science is sizzling, but business is tough for many: mergers, cash shortages, gyrating share prices, regulatory tangles. And as always in the business of science, it's tougher in Europe than in the U.S.
NOTABLE QUOTE
